Merus Announces First Patient Treated in Phase 1/2 Clinical Trial of MCLA-129 in Advanced Lung …,

Merus’ Fourth Sponsored Bispecific Antibody Currently in Clinical Trials. UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 03, 2021 …, Merus’ Fourth Sponsored Bispecific Antibody Currently in Clinical Trials. UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 03, 2021 …, Read More

Scroll to Top